Page last updated: 2024-08-25

3-deazaneplanocin and Androgen-Independent Prostatic Cancer

3-deazaneplanocin has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aparicio, A; Chung, W; Estécio, MR; Issa, JP; Jelinek, J; Kleb, B; Maity, S; Marquez, VE; Navone, NM; Tahir, S; Tzelepi, V; Zhang, J	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Androgen-Independent Prostatic Cancer

Article	Year
Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics, 2016, 03-03, Volume: 11, Issue:3 Topics: Adenosine; Animals; Carcinoma, Small Cell; Cell Line, Tumor; Cell Lineage; CpG Islands; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Xenograft Model Antitumor Assays	2016

Article

Year

Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas.

Epigenetics, 2016, 03-03, Volume: 11, Issue:3

Topics: Adenosine; Animals; Carcinoma, Small Cell; Cell Line, Tumor; Cell Lineage; CpG Islands; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Xenograft Model Antitumor Assays

2016